Print the page
Increase font size
One Thing AI Can’t Do

One Thing AI Can’t Do

Chris Campbell

Posted August 30, 2024

Chris Campbell

This year, I’ve become a bit of a mead maniac—obsessed with brewing the perfect batch.

Making mead is like stepping back in time.

It's an ancient art, a ritual that’s been passed down through generations.

You start with simple ingredients: honey, water, and yeast. Maybe you get a little creative and add herbs.

(The Celts used heather flowers in their mead for its medicinal properties. The Vikings used meadowsweet. The Greeks? Hyssop. The list goes on.)

But the magic happens in the wait.

Mead is a slow brew.

We’re talking months, sometimes even years. You don’t rush it because you can’t. You let nature do its thing, allowing the flavors to evolve, deepen, and mature.

This deliberate process is part of what makes mead so special.

It’s what gives mead its character, its soul.

But let’s be real—few things in life need to take this long.

Some things, like saving lives, don’t get better by hiding them in a dark closet and waiting. They demand speed, precision, and urgency.

Unlike mead, which SHOULD take time, discovering and developing life-saving drugs is an area where speed matters—a lot.

Every day, every week shaved off the drug discovery process can mean the difference between life and death for countless people.

For decades, drug discovery has been this slow, grueling process.

You had scientists in lab coats hunched over microscopes, trying to figure out which molecules might, just might, be the magic bullet for some disease.

It took years, sometimes decades, and billions of dollars.

And even then, more than half of those drugs didn’t make it past the first phase of trials.

But now, AI is stepping into the ring…

The AI Drug Rush

And it’s not just frolicking in the fringes—it’s beginning to dominate. The mainstream media isn’t reporting on it, but it’s happening.

We’re talking about a leap from a 63% success rate in Phase 1 trials to a mind-blowing 80-90% success rate.

Our colleague Ray Blanco calls it the “AI Drug Rush.”

And this is the kind of rush that only comes around once in a generation.

Our main beat here in ALC: It pays to be optimistic.

The Fallen Angel Trade

Posted October 21, 2026

By Ray Blanco

Ray Blanco reveals his method…

Biotech’s Milkshake Moment

Posted October 20, 2026

By Chris Campbell

A $400 billion patent cliff, AI-built drugs and a flood of 100% days. That’s a setup for a supercycle.

Forget the Flying Car

Posted October 16, 2026

By Chris Campbell

If a big AI bust happens, here’s the silver lining.

Clonemageddon!

Posted October 15, 2026

By Chris Campbell

If a kid can rebuild it in a weekend, don’t own it.

Nobody Told the Robots

Posted October 14, 2026

By Chris Campbell

So here’s the rule. When a scary headline hits, ask one question: Do the machines still need it? If the answer’s yes, the headline is noise.

The Robotaxi Refund

Posted October 13, 2026

By Chris Campbell

In 1900, Fifth Avenue was disgusting.